Myomo Inc (STU:0M61)
€ 5.99 0.22 (3.81%) Market Cap: 195.61 Mil Enterprise Value: 189.56 Mil PE Ratio: 0 PB Ratio: 20.39 GF Score: 55/100

Myomo Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript

Sep 21, 2021 / 04:25PM GMT
Release Date Price: €9.9 (+3.13%)
Steve Lichtman
Oppenheimer & Co. Inc. - Analyst

Hi, everyone. I am Steve Lichtman, Medical Devices Analyst at Oppenheimer. Welcome back to the Fall Oppenheimer Healthcare Summit. Very happy to have with us up next, Myomo Incorporated. With us today is Paul Gudonis, Chairman and CEO, and Dave Henry, CFO.

I'm going to turn the podium over to Paul and Dave for a presentation, and then we should have a few minutes for a Q&A at the end. You can key your questions in, and I'll make sure to get them over to management. And with that, I will turn the call over to Paul. Thanks, Paul.

Paul Gudonis
Myomo, Inc. - Chairman & CEO

Thank you for this opportunity to introduce Myomo to you. We are a wearable medical robotics company that is conquering paralysis for these individuals who suffer from upper limb paralysis due to stroke, spinal cord and other neurological injuries. We are traded on the New York Stock Exchange American under the symbol MYO. This is our safe harbor statement since we will be making forward-looking statements during our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot